Summary
Alterations of glucose metabolism occur frequently in association with pancreatic cancer. Whether diabetes predisposes or is a consequence of pancreatic cancer has not been settled. We have found that induced diabetes prevents development of pancreatic cancer in the hamster model and that genetically diabetic Chinese hamsters resist pancreatic cancer induction, whereas the nondiabetic strain does not. Also, preliminary clinical data indicates that diabetes is associated with pancreatic cancer and that the two conditions develop simultaneously. We have found diabetes or impaired glucose tolerance in 76% of the pancreatic cancer patients at the time of cancer diagnosis. The diabetic condition improved after 75% pancreatectomy. Although the preliminary observations suggest that diabetes accompanies the disorder of pancreatic cancer, additional data are needed before any conclusion can be drawn.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Zimmerman B. Editorial. Diabetes and gross lesions of the pancreas. J. Clin. Endocrinol. Metab. 1954; 14: 481–483.
Bell ET. Carcinoma of the pancreas II. The relation of carcinoma of the pancreas to diabetes mellitus. Am. J. Pathol. 1957; 33: 499–523.
Schwarz SS, Zeidler A, Moossaa AR, et al. A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma. Dig. Dis. 1978; 23: 1107–1114.
Levin DL, Connelly RR. Cancer of the pancreas. Cancer 1973; 31: 1231–1236.
Wood RA, Schwarz SS, Rubenstein AH, Moossa AR. A prospective evaluation of glucose intolerance in patients suspected of having pancreatic cancer. Br. J. Surg. 1978; 65: 815.
Soler NG, Exon PD, Paton A. Carbohydrate tolerance and insulin response in obstructive jaundice. Br. Med. J. 1974; 4: 447–449.
Clark CG, Mitchell PEG. Diabetes mellitus and primary cancer of the pancreas. Br. Med. J. 1961; 2: 1256–1262.
Green RC, JR, Bagenstoss AH, Sprague RG. Diabetes mellitus in association with primary carcinoma of pancreas. Diabetes 1958; 7: 308–311.
Murphy R, Smith FH. Abnormal carbohydrate metabolism in pancreatic carcinoma. Med. Clin. North Am. 1963; 47: 397–405.
McKidde MT, Buchanan KD, McBain GC, Bell G. The Insulin response to glucose in patients with pancreatic disease. Postgraduate Medical Journal 1969; 45: 726–728.
Pour PM. Experimental pancreatic cancer. Am. J. Surg. Pathol. 1989; 13: 96–103.
Pour PM, Kazakoff K, Carlson K. Inhibition of streptozotocin-induced islet call tumors and BOP-induced exogenous pancreatic tumors in Syrian hamsters. Cancer Res. 1990; 50: 1634–1639.
Pour PM, Bell R. Induction of pancreatic exocrine tumors in non-diabetic but not in diabetic Chinese hamsters. Pancreas Club Meeting, New York, May 14, 1985.
Pour PM, Stepan K. Modification of pancreatic carcinogensis in the hamster model. VIII. Inhibitory effect of exogenous insulin. J. Natl. Cancer Inst. 1984; 72: 1205–1208.
Bell RH, McCullough PJ, Pour PM. Influence of diabetes on susceptibility to experimental pancreatic cancer. Am. J. Surg. 1988; 155: 159–164.
Irving I. Cancer mortality among diabetes. J. Natl. Cancer Inst. 1970; 44: 673–686.
De Fronzo RA, Tobin TD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am. J. Physiol. 1979; 237: E214–132.
Permert J, Larsson J, Jorfeldt L, Arnquist H, von Schenck H, Ihse I. Is pancreatic cancer associated with s special form of diabetes? Digestion 1990; 46(3): 169.
Permert J, Larsson J, Jorfeldt L, Arnquist H, von Schenck K, Ihse I. Diabetes does not follow extensive subtotal pancreatectomy (STP). Digestion 1990; 46(3): 168.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Permert, J., Larsson, J., Ihse, I. et al. Diagnosis of pancreatic cancer. Int J Pancreatol 9, 113–117 (1991). https://doi.org/10.1007/BF02925586
Issue Date:
DOI: https://doi.org/10.1007/BF02925586